Aclarion Inc (ACON)

07:58 AM

Aclarion Announces Texas Back Institute as New CLARITY Trial Site - The Manila Times

07:58 AM

07:45 AM

Aclarion Inc. Partners with Texas Back Institute for CLARITY Clinical Trial to Enhance Chronic Low Back Pain Treatment - Nasdaq

07:45 AM

07:15 AM

History Says Now Is the Time to Buy Nvidia Stock - The Globe and Mail

07:15 AM

May 05, 2025

Aclarion Welcomes Advocate Health as CLARITY Trial Site - Ortho Spine News

May 05, 2025

May 05, 2025

Major Breakthrough: Advocate Health to Test AI-Powered Spine Pain Diagnostic in 300-Patient Trial - Stock Titan

May 05, 2025

May 03, 2025

Aclarion secures funding for pivotal CLARITY trial - MSN

May 03, 2025

Apr 29, 2025

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana - Ortho Spine News

Apr 29, 2025

Apr 29, 2025

Aclarion (ACON) Partners with Louisiana Spine Institute to Expan - GuruFocus

Apr 29, 2025

Apr 29, 2025

Aclarion announces agreement with the Spine Institute of Louisiana - TipRanks

Apr 29, 2025

Apr 29, 2025

Aclarion Expands Nociscan Access with Commercial Agreement at Spine Institute of Louisiana - Nasdaq

Apr 29, 2025

Apr 29, 2025

Revolutionary Spine Pain Technology Nociscan Achieves 97% Success Rate, Expands to 17 Medical Centers - Stock Titan

Apr 29, 2025

Apr 28, 2025

Aclarion stock hits 52-week low at $7.25 amid steep annual decline By Investing.com - Investing.com South Africa

Apr 28, 2025

Apr 28, 2025

Aclarion stock hits 52-week low at $7.25 amid steep annual decline - Investing.com

Apr 28, 2025

Apr 27, 2025

Aclarion, Inc. (NASDAQ:ACON) Short Interest Update - Defense World

Apr 27, 2025

Apr 25, 2025

Aclarion Inc Files For Mixed Shelf Of Up To $150 MlnSEC Filing - marketscreener.com

Apr 25, 2025

Apr 23, 2025

Aclarion Releases Updated Investor Presentation at Showcase - TipRanks

Apr 23, 2025

Apr 23, 2025

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 - The Manila Times

Apr 23, 2025

Apr 23, 2025

Aclarion, Inc. to Present at Planet MicroCap Showcase: VEGAS 2025 on Chronic Low Back Pain Solutions - Nasdaq

Apr 23, 2025

Apr 23, 2025

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet ... - Bluefield Daily Telegraph

Apr 23, 2025

Apr 23, 2025

Aclarion's Revolutionary AI Approach to Chronic Back Pain: New Investor Strategy Revealed at MicroCap Vegas - Stock Titan

Apr 23, 2025

Apr 22, 2025

3 Reasons to Buy Amazon Stock Like There's No Tomorrow - The Globe and Mail

Apr 22, 2025

Apr 21, 2025

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis - Ortho Spine News

Apr 21, 2025

Apr 21, 2025

Aclarion's Nociscan Demonstrates Cost-Effectiveness and Improved Surgical Success Compared to Provocative Discography - Nasdaq

Apr 21, 2025

Apr 21, 2025

New Research: AI-Powered Spine Technology Cuts Patient Costs by $1,712, Boosts Surgery Success 10% - Stock Titan

Apr 21, 2025

Apr 12, 2025

NOCISCAN touted as lumbar pain diagnostic advance - MSN

Apr 12, 2025

Apr 11, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Apr 11, 2025

Apr 09, 2025

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub - The Manila Times

Apr 09, 2025

Apr 09, 2025

Aclarion, Inc. SEC 10-K Report - TradingView

Apr 09, 2025

Apr 08, 2025

Aclarion stock hits 52-week low at $9.68 amid steep annual decline - Investing.com Canada

Apr 08, 2025

Apr 07, 2025

Aclarion stock hits 52-week low at $9.68 amid steep annual decline By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 02, 2025

Aclarion ‘s Nociscan now available in Santa Monica at MICSC - TipRanks

Apr 02, 2025

Apr 02, 2025

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California - The Manila Times

Apr 02, 2025

Apr 01, 2025

EXCLUSIVE: March's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank?Apple (NASDAQ:AAPL), Aclarion (NASDAQ:ACON) - Benzinga

Apr 01, 2025

Mar 31, 2025

Aclarion, Inc. Delays Annual Report Filing - TipRanks

Mar 31, 2025

Mar 31, 2025

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives - Ortho Spine News

Mar 31, 2025

Mar 31, 2025

Aclarion provides corporate update following Q1 strategic initiatives - TipRanks

Mar 31, 2025

Mar 27, 2025

Aclarion, Inc. (NASDAQ:ACON) Short Interest Down 73.9% in March - Defense World

Mar 27, 2025

Mar 26, 2025

Aclarion stock plunges to 52-week low of $0.51 amid steep decline By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Aclarion announces 1-for-27 reverse stock split By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Aclarion Announces Reverse Stock Split - OrthoSpineNews

Mar 26, 2025

Mar 26, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 26, 2025

Mar 26, 2025

Crude Oil Gains Over 1%; Cintas Shares Jump After Q3 Earnings - Benzinga

Mar 26, 2025

Mar 26, 2025

Nasdaq Down 1%; Dollar Tree To Sell Family Dollar Business For $1 Billion - Benzinga

Mar 26, 2025

Mar 26, 2025

Aclarion stock plunges to 52-week low of $0.51 amid steep decline - Investing.com

Mar 26, 2025

Mar 26, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mar 26, 2025

Mar 26, 2025

Aclarion announces 1-for-27 reverese stock split - TipRanks

Mar 26, 2025